首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Immunological unresponsiveness in chimeric miniature swine following MHC-mismatched spleen transplantation.
【24h】

Immunological unresponsiveness in chimeric miniature swine following MHC-mismatched spleen transplantation.

机译:MHC不匹配的脾脏移植后嵌合小型猪的免疫学无反应性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: In rodents, spleen allotransplantation (SpTx) induces tolerance. We investigated the induction of chimerism and donor-specific unresponsiveness following pig SpTx. METHODS: Thirteen pigs underwent splenectomy (day 0); all received a blood transfusion. In 11/13 pigs, SpTx was performed across a MHC class I (n=1) or full (n=10) barrier; two control pigs received no SpTx. All pigs were monitored for chimerism, and anti-donor immune responses, including suppressor assays. Four pigs (two asplenic controls and two with SpTx) underwent delayed donor-matched kidney transplantation without immunosuppression. RESULTS: Six of the 11 spleen grafts were lost from rejection (n=5) or splenic vein thrombosis (n=1), and five remained viable. All 11 SpTx recipients developed multilineage chimerism, but chimerism was rapidly lost if the graft failed. Two control pigs showed <6% blood chimerism for 4 and 11 days only. Pigs with functioning spleen grafts had multilineage chimerism in blood, thymus and bone marrow for at least 2-6 months, without graft-versus-host disease. These pigs developed in vitro donor-specific hyporesponsiveness and suppression. In 2 pigs tolerant to the spleen graft, donor MHC-matched kidney grafts survived for >4 and >7 months in the absence of exogenous immunosuppression; in two asplenic pigs, kidney grafts were rejected on days 4 and 15. CONCLUSIONS: Successful SpTx can result in hematopoietic cell engraftment and in vitro donor-specific unresponsiveness, enabling prolonged survival of subsequent donor-matched kidney grafts without immunosuppression.
机译:背景:在啮齿动物中,脾同种异体移植(SpTx)诱导耐受。我们调查了猪SpTx后嵌合体的诱导和供体特异性无反应性。方法:13只猪接受了脾切除术(第0天);所有人都接受了输血。在11/13头猪中,SpTx跨MHC I类(n = 1)或完全(n = 10)屏障进行;两只对照猪未接受SpTx。监测所有猪的嵌合体和抗供体免疫应答,包括抑制试验。 4头猪(2例无规对照和2例带有SpTx)进行了延迟供体匹配的肾脏移植,未进行免疫抑制。结果:11例脾脏移植中有6例因排斥反应(n = 5)或脾静脉血栓形成(n = 1)丢失,其中5例仍然可行。所有11个SpTx受体接受者均形成多谱系嵌合体,但是如果移植失败,嵌合体将迅速丧失。两只对照猪仅在第4天和第11天表现出<6%的血液嵌合率。具有脾脏移植功能的猪在血液,胸腺和骨髓中具有至少2-6个月的多谱系嵌合现象,没有移植物抗宿主病。这些猪出现了体外供体特异性低反应性和抑制性。在2只耐受脾移植的猪中,供体MHC匹配的肾脏移植在没有外源性免疫抑制的情况下存活了> 4和> 7个月。在两只无足轻重的猪中,第4天和第15天拒绝了肾移植。结论:成功的SpTx可以导致造血细胞移植和体外供体特异性无反应,从而可以在不进行免疫抑制的情况下延长后续供体匹配的肾移植的存活时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号